作者
Ricardo D'Oliveira Vieira, Whady Hueb, Mark Hlatky, Desiderio Favarato, Paulo Cury Rezende, Cibele Larrosa Garzillo, Eduardo Gomes Lima, Paulo Rogério Soares, Alexandre Ciappina Hueb, Alexandre Costa Pereira, José Antonio Franchini Ramires, Roberto Kalil Filho
发表日期
2012/9/11
期刊
Circulation
卷号
126
期号
11_suppl_1
页码范围
S145-S150
出版商
Lippincott Williams & Wilkins
简介
Background
The Second Medicine, Angioplasty, or Surgery Study (MASS II) included patients with multivessel coronary artery disease and normal systolic ventricular function. Patients underwent coronary artery bypass graft surgery (CABG, n= 203), percutaneous coronary intervention (PCI, n= 205), or medical treatment alone (MT, n= 203). This investigation compares the economic outcome at 5-year follow-up of the 3 therapeutic strategies.
Methods and Results
We analyzed cumulative costs during a 5-year follow-up period. To analyze the cost-effectiveness, adjustment was made on the cumulative costs for average event-free time and angina-free proportion. Respectively, for event-free survival and event plus angina-free survival, MT presented 3.79 quality-adjusted life-years and 2.07 quality-adjusted life-years; PCI presented 3.59 and 2.77 quality-adjusted life-years; and CABG demonstrated 4.4 and 2.81 quality …
引用总数
2013201420152016201720182019202020212022202320241027478427121